Stay updated with breaking news from Laboratories Profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HYA Advisors Inc decreased its holdings in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 7.9% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,999 shares of the healthcare product maker’s stock after selling 171 shares during the quarter. […]
Sara Bay Financial reduced its position in Abbott Laboratories (NYSE:ABT – Get Rating) by 6.4% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 8,237 shares of the healthcare product maker’s stock after selling 564 shares during the period. Abbott Laboratories accounts for approximately 0.4% of Sara […]
Global Therapeutic Drug Monitoring Market report contains financials regarding base year and forecasting period revenue. The chapters of the report are...
Pune, April 07, 2022 (GLOBE NEWSWIRE) -- Global Therapeutic Drug Monitoring Market 2022Global Therapeutic Drug Monitoring Market research report measu
Robeco Institutional Asset Management B.V. trimmed its holdings in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 0.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 648,581 shares of the healthcare product maker’s stock after selling 5,053 shares during the period. Robeco Institutional Asset […]